Please use the search box, or navigate using the categories from the home page.
If you have specific questions, a chat facility is available.
Brain Tumour Research Appeal
Lions Brain Tumour Research Appeal
|Name:||Mary Ann Woodman|
|MD title||Lions Brain Tumour Research Lead|
|Email:||firstname.lastname@example.org or email@example.com|
Lions Clubs International (MD105) British Isles is working in partnership with Brain Tumour Research to raise £1 million over four years to help fund game-changing research and raise awareness of the impact of brain tumours.
Brain Tumour Research is dedicated to raising funds for continuous and sustainable scientific research into brain tumours. It supports one of the UK’s largest collaborative groups of laboratory-based scientists.
At the end of the partnership, a laboratory in one of Brain Tumour Research’s dedicated research centres will be named after Lions Clubs International – British Isles, creating a legacy in recognition of the contribution of its members and their local communities to improve the lives of brain tumour patients and their families.
Key facts from Brain Tumour Research
Brain Tumour Research is the only national charity in the UK dedicated to raising funds for continuous and sustainable scientific research into brain tumours, and is a leading voice calling for greater support and action for research into what scientists are calling the last battleground against cancer.
- Brain tumours are indiscriminate; they can affect anyone at any age.
- Brain tumours kill more children and adults under the age of 40 than any other cancer.
- Historically, just 1% of the national spend on cancer research has been allocated to brain tumours.
- In the UK, 16,000 people each year are diagnosed with a brain tumour.
- Brain tumours kill more children than leukaemia.
- Brain tumours kill more men under 45 than prostate cancer.
- Brain tumours kill more women under 35 than breast cancer.
- Less than 20% of those diagnosed with a brain tumour survive beyond five years compared with an average of 50% across all cancers.